Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 7.4B | 7.7B | 7.1B | 7.2B |
Cost of revenue | 2.6B | 2.7B | 2.4B | 2.5B |
Gross profit | 4.8B | 5.0B | 4.7B | 4.7B |
Operating expense | ||||
Research & development | 624.3M | 588.2M | 580.4M | 599.4M |
Selling general and admin | 2.4B | 2.3B | 2.3B | 2.4B |
Other operating expenses | 60.2M | 12.9M | -4.3M | -29.2M |
Operating income | 1.3B | 1.5B | 1.5B | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 151.3M | 149.6M | 153.9M | 179.7M |
Other income expense | -33.5M | -310.4M | 6.0M | 123.0M |
Pretax income | 1.1B | 1.1B | 1.3B | 1.3B |
Tax provision | 219.3M | 171.1M | 203.8M | 241.6M |
Net income | 900.3M | 912.4M | 1.1B | 1.1B |
Basic EPS | 0.8 | 0.8 | 1.0 | 1.0 |
Diluted EPS | 0.8 | 0.8 | 1.0 | 1.0 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 2.0B | 2.3B | 2.1B | 2.1B |
Net income from continuing op. | 900.3M | 912.4M | 1.1B | 1.1B |
Minority interests | -6.0M | -4.3M | -7.7M | -7.7M |
Preferred stock dividends | — | — | — | — |